Bit Capital Gmb H Actinium Pharmaceuticals, Inc. Transaction History

Bit Capital Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Feb 12, 2025	SELL	$1.72 - $8.0 $154,228 - $717,344	-89,668 Closed	0 $0
Q1 2024 Feb 12, 2025	BUY	$5.0 - $9.2 $349,460 - $643,006	69,892 Added 353.42%	89,668 $702 Million
Q4 2023 Feb 12, 2025	BUY	$4.02 - $6.08 $79,499 - $120,238	19,776 New	19,776 $100 Million
Q4 2021 Feb 12, 2025	SELL	$6.01 - $8.8 $84,741 - $124,080	-14,100 Closed	0 $0
Q1 2021 Feb 12, 2025	BUY	$7.62 - $9.79 $107,442 - $138,039	14,100 New	14,100 $107 Million

8.47M

65.2K

21.7K

Ticker ATNM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,184,700
Market Cap $28.2M
Description
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.